Saini, Neeraj
Neelapu, Sattva S. http://orcid.org/0000-0003-1045-4914
Article History
First Online: 15 September 2022
Competing interests
: S.S.N. received research support from Kite/Gilead, BMS, Cellectis, Poseida, Allogene, Unum Therapeutics, Precision Biosciences, and Adicet Bio; served as Advisory Board Member/Consultant for Kite/Gilead, Merck, Novartis, Sellas Life Sciences, Athenex, Allogene, Incyte, Adicet Bio, BMS, Legend Biotech, Bluebird Bio, Fosun Kite, Sana Biotechnology, Caribou, Astellas Pharma and Morphosys; has received royalty income from Takeda Pharmaceuticals; has stock options from Longbow Immunotherapy; and has intellectual property related to cell therapy.